Joseph Cappello's Insider Trades & SAST Disclosures

Joseph Cappello's most recent trade in Genelux Corp was a trade of 4,737 Common Stock done at an average price of $2.9 . Disclosure was reported to the exchange on May 12, 2025.

Share

Note

This is a custom search result for pattern Joseph Cappello.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Genelux Corp	Joseph Cappello	VP, Pharmaceutical Development	Sale of securities on an exchange or to another person at price $ 2.92 per share.	12 May 2025	4,737	52,266	-	2.9	13,832	Common Stock
Genelux Corp	Joseph Cappello	VP, Pharmaceutical Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Mar 2025	13,350	57,003	-		0	Common Stock
Genelux Corp	Cappello Joseph	VP, Pharmaceutical Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Dec 2024	39,000	39,000	-		-	Stock Option (right to buy)
Genelux Corp	Joseph Cappello	VP, Pharmaceutical Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Dec 2024	29,000	43,653	-		0	Common Stock
Genelux Corp	Cappello Joseph	VP, Pharmaceutical Development	Sale of securities on an exchange or to another person at price $ 2.34 per share.	16 Dec 2024	6,300	14,653	-	2.3	14,742	Common Stock
Genelux Corp	Joseph Cappello	VP, Pharmaceutical Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2024	11,557	20,953	-		0	Common Stock
Genelux Corp	Joseph Cappello	VP, Pharmaceutical Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2024	3,661	9,396	-		0	Common Stock
Genelux Corp	Joseph Cappello	VP, Pharmaceutical Development	Sale of securities on an exchange or to another person at price $ 23.73 per share.	18 Aug 2023	3,265	5,735	-	23.7	77,478	Common Stock
Genelux Corp	Joseph Cappello	VP, Pharmaceutical Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Feb 2023	9,000	9,000	-		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades